Ben Haynor's questions to OrthoPediatrics Corp (KIDS) leadership • Q2 2025
Question
Ben Haynor of Lake Street Capital Markets questioned the company's preference between acquisition versus de novo expansion for its OPSB business and asked if the anticipated 'halo effect' from the EOS portfolio development is already materializing.
Answer
CEO Dave Bailey clarified that the company prefers Greenfield (de novo) expansion in established territories and acqui-hires in new jurisdictions to build an initial footprint. He confirmed that the 'halo effect' from their investment in the EOS portfolio is already benefiting the broader scoliosis business by creating new opportunities with customers for their existing fusion products.